N/A
Completed N=1,635
Breast Cancer Risk Reduction: A Patient Doctor Intervention
Source: ClinicalTrials.gov NCT01830933 ↗Enrolled (actual)
1,635
Serious AEs
0.0%
Results posted
May 2013
Primary outcomePrimary: Knowledge of Breast Cancer Risk Factors — 48.9; 56.4 units on a scale
Summary
The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Knowledge of Breast Cancer Risk Factors |
48.9; 56.4 | — |
| PRIMARY Percentage of Participants With Correct Perception of Risk |
69.9; 65.9; 73.3; 71.1 | — |
| PRIMARY Percentage of Participants Who Had a Discussion of Breast Cancer Risk |
15; 41 | — |
| PRIMARY Percentage of Participants Who Reported Discussion of Mammography Screening |
51.6; 61.5 | — |
Eligibility Criteria
Inclusion Criteria
- Patient component:
- Women who visit the General Internal Medicine (GIM) practices at SFGH and UCSF during the study period
- Between the ages of 40 and 74
- Self-identify as Asian American, Spanish- and English-speaking Latinas, African American, or White
- Have no history of breast cancer are eligible to participate.
- Physician component: Primary care physicians currently practicing at the GIM clinics at SFGH and UCSF
Exclusion Criteria
- Patient component: Women whose physicians object to their participation in the study
- Physician component: No exclusion criteria for physicians
Data sourced from ClinicalTrials.gov (NCT01830933). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.